B6.Cg-Tg(FCGRT)32Dcr Alb^em12Mvw Fcgrt^tm1Dcr/MvwJ

Stock number: 025201
Product name: FcRn-/- hFcRn (32) Tg; Alb KO , hFcRn Tg32; Alb KO
Research areas: Immunology, Inflammation and Autoimmunity Research, Metabolism Research, Research Tools

Description

This TALEN-mediated deletion in Alb results in the absence of any albumin protein in the blood. When combined with the knockout allele of the FcRn a-chain and a transgene expressing a human FcRn a-chain (FCGRT) under control of the human FcRn promoter, this albumin-deficient model may be useful for studying human serum albumin pharmacokinetics.

Need assistance evaluating antibodies in FcRn mice? Human preclinical pharmacokinetic (PK) analysis is available. See our FcRn full service platform.

Detailed description

Mice homozygous for the Alb^em12Mvw allele lack albumin protein in their blood. FcRn-/- hFcRn (32) Tg mice harbor a knockout allele of the Fc receptor, IgG, alpha chain transporter (Fcgrt^tm1Dcr) and express a human FcRn a-chain (FCGRT) transgene under control of the human FcRn promoter. Mouse IgG levels are low due to the species-specific activity of human FcRn. Mice do not exhibit any gross abnormal phenotype. This albumin-deficient model may be useful for studying the biology and pathobiology of serum albumin as well as evaluating human albumin pharmacokinetics.

C57BL/6J-Alb^em8Mvw/MvwJ (Stock No. 025200) was generated as a control for this strain.

Development

A targeting scheme was designed using a TALEN-mediated Non-Homologous End Joining (NHEJ) repair pathway to knock out the mouse albumin gene in B6.Cg-Fcgrt^tm1Dcr Tg(FCGRT)32Dcr/DcrJ (Stock No. 014565). TALEN mRNAs were introduced into mutant zygotes, and the resulting founder mouse (#6074) was crossed to a B6.Cg-Fcgrt^tm1Dcr Tg(FCGRT)32Dcr/DcrJ mouse in order to characterize the mutation, a 2-base deletion resulting in early termination of the translated protein. N1 Heterozygous offspring were filial-crossed to establish the colony as homozygotes.

Allele

Symbol: Alb^em12Mvw
Name: endonuclease-mediated mutation 12, Michael Wiles
MGI accession ID: MGI:5494605
Generation method: Endonuclease-mediated
Attributes: Null/Knockout
Marker symbol: Alb
Marker name: albumin
Chromosome: 5
Strain of origin: B6.Cg-Fcgrt^tm1Dcr Tg(FCGRT)32Dcr/DcrJ
Molecular note: Exon 4 was targeted by introduction of TALEN mRNA into fertilized B6.Cg-Fcgrt^tm1Dcr Tg(FCGRT)32Dcr/DcrJ oocytes and the resulting founder screened and found to have a 2 base pair deletion beginning at Chromosome 5 base 90,464,113 (GRCm38.p2) which is predicted to result in a frame shift then a premature stop codon 5 amino acids downstream of the encoded frame shift. By ELISA, heterozgyotes have a decrease in serum albumin of approximately 30 percent and homozygotes have no detectable serum albumin.

Allele

Symbol: Fcgrt^tm1Dcr
Name: targeted mutation 1, Derry C Roopenian
MGI accession ID: MGI:3511510
Generation method: Targeted
Attributes: Null/Knockout
Marker symbol: Fcgrt
Marker name: Fc receptor, IgG, alpha chain transporter
Chromosome: 7
Strain of origin: 129X1/SvJ
Molecular note: Sequence from exon 1 and part of exon2 was replaced with a PGK-neo cassette. Quantitative PCR of liver cDNA indicated the absence of mRNA. Western blot analysis of neonatal intestinal extracts failed to reveal protein product.

Allele

Symbol: Tg(FCGRT)32Dcr
Name: transgene insertion 32, Derry C Roopenian
MGI accession ID: MGI:4944199
Generation method: Transgenic
Attributes: Inserted expressed sequence; Humanized sequence
Marker symbol: Tg(FCGRT)32Dcr
Marker name: transgene insertion 32, Derry C Roopenian
Chromosome: 2
Strain of origin: C57BL/6J
Expressed genes: FCGRT,Fc fragment of IgG receptor and transporter,human
Site of expression: The transgene expresses human FCGRT from the native human promoter, and displays a physiological human FCGRT expression pattern (Latvala et al., 2017).
Molecular note: A 34Kb fragment of a BAC containing the entire human FCGRT , Fc fragment of IgG, receptor, transporter, alpha, gene (approximately 11kb) and approximately 10kb of flanking sequence was sublconed into a SuperCos vector. The resulting cosmid was microinjected into fertilized C57BL/6J mouse eggs. Founder line 32 was established. Transgene insertion occurred on Chr 2.